These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19125098)

  • 1. Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia.
    Bohnstedt C; Taskinen M; Zeller B; Björgvinsdóttir H; Hafsteinsdottir S; Schmiegelow K
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):79-80. PubMed ID: 19125098
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance chemotherapy of acute lymphoblastic leukemia in children.
    Schmiegelow K
    Dan Med Bull; 1998 Nov; 45(5):510-32. PubMed ID: 9850812
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
    Shah N; Al-Ahmari A; Al-Yamani A; Dupuis L; Stephens D; Hitzler J
    Pediatr Blood Cancer; 2009 Jan; 52(1):14-9. PubMed ID: 18802938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K; Heyman M; Kristinsson J; Mogensen UB; Rosthøj S; Vettenranta K; Wesenberg F; Saarinen-Pihkala U;
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute lymphoblastic leukemia: protocol Fralle 83-85.
    Schaison G; Olive D; Leverger G; Vannier JP; de Lumley L; Bancillon A; Cornu G
    Haematol Blood Transfus; 1990; 33():467-72. PubMed ID: 2182438
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group--protocol ALL-99.
    Brandalise SR; Pinheiro VR; Aguiar SS; Matsuda EI; Otubo R; Yunes JA; Pereira WV; Carvalho EG; Cristofani LM; Souza MS; Lee ML; Dobbin JA; Pombo-de-Oliveira MS; Lopes LF; Melnikoff KN; Brunetto AL; Tone LG; Scrideli CA; Morais VL; Viana MB
    J Clin Oncol; 2010 Apr; 28(11):1911-8. PubMed ID: 20212252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
    Ochocka M; Zelenay E
    Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recurrences after completion of the treatment of acute lymphoblastic leukemia in children].
    Ochocka M; Matysiak M; Newecka-Samól T; Kulus M; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Jackowska T; Jakowicka M
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):350-3. PubMed ID: 1437752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication errors on oral chemotherapy in children with acute lymphoblastic leukemia in a developing country.
    Oberoi S; Trehan A; Marwaha RK
    Pediatr Blood Cancer; 2014 Dec; 61(12):2218-22. PubMed ID: 25175850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
    Desai SJ; Barr RD; Andrew M; deVeber LL; Pai MK
    CMAJ; 1989 Oct; 141(7):693-7. PubMed ID: 2790605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down syndrome and acute lymphoblastic leukaemia.
    Whitlock JA
    Br J Haematol; 2006 Dec; 135(5):595-602. PubMed ID: 17054672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High methotrexate doses in the treatment program for acute lymphoblastic leukemia and lymphosarcoma in children].
    Makhonova LA; Maiakova SA; Kiselev AV; Gordina GA; Balakirev SA; Gavrilova IE; Moiseenko EI; Morozova OV
    Vopr Onkol; 1990; 36(10):1196-200. PubMed ID: 2251813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute leukemias in children with Down syndrome.
    Zwaan MC; Reinhardt D; Hitzler J; Vyas P
    Pediatr Clin North Am; 2008 Feb; 55(1):53-70, x. PubMed ID: 18242315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Second cessation of therapy in children with acute lymphoblastic leukemia].
    Rokicka-Milewska R; Derulska D; Jackowska T; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Cyklis R; Duczmal B; Jakowicka M
    Acta Haematol Pol; 1992; 23(1):43-7. PubMed ID: 1615750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clotting abnormalities in children during maintenance chemotherapy for acute lymphoblastic leukemia.
    Aricò M; Gamba G; Raiteri E; Montani N; De Amici M; Burgio GR
    Haematologica; 1991; 76(6):472-4. PubMed ID: 1820983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia.
    Bohnstedt C; Levinsen M; Rosthøj S; Zeller B; Taskinen M; Hafsteinsdottir S; Björgvinsdóttir H; Heyman M; Schmiegelow K;
    Leukemia; 2013 Apr; 27(4):866-70. PubMed ID: 23138181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991.
    Mauger DC; Skeen JE
    N Z Med J; 1998 Nov; 111(1078):454-6. PubMed ID: 9891565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late recurrence (11 years) in a case of ALL. Recurrence or a second disease?].
    García Zueco JC; Torres Gómez M; López Gómez L; Martín Guerrero Y
    Sangre (Barc); 1992 Apr; 37(2):152-3. PubMed ID: 1621188
    [No Abstract]   [Full Text] [Related]  

  • 20. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia.
    Halonen P; Salo MK; Mäkipernaa A
    J Pediatr; 2001 Mar; 138(3):428-31. PubMed ID: 11241057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.